Portal hypertensive gastropathy

Digestive Diseases

Volumn 14, Issue 4, 1996, Pages 258-270

  Trevino, Hector H ^a   Brady, Charles E ^a   Schenker, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Congestive gastropathy; Gastrointestinal hemorrhage; Portal hypertension; Portal hypertensive gastropathy

Indexed keywords

CHRONIC DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; METHODOLOGY; MICROCIRCULATION; PATHOLOGY; PHYSIOLOGY; PORTAL HYPERTENSION; REVIEW; SCLEROTHERAPY; STOMACH MUCOSA; SYNDROME; VASCULARIZATION;

CHRONIC DISEASE; ENDOSCOPY, GASTROINTESTINAL; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; MICROCIRCULATION; SCLEROTHERAPY; SYNDROME;

EID: 0030183580     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171557     Document Type: Article

References (106)

1. McCormack TT, Sim J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR: Gastric lesions in portal hypertension: Inflammatory gastritis or congestive gastropathy? Gut 1985;26:1226-1232.
2. Tamawski AS, Sarfeh IJ, Stachura J, Hajduczck A, Bui HX, Dabros W, Gergely H: Microvascular abnormalities of the portal hypertensive gastric mucosa, Hepatology 1988:8: 1488-1494.
3. Sarfeh IJ, Soliman H, Waxman K, Coccia M, Rypins EB, Bui HX, Tar-nawski A: Impaired oxygenation of gastric mucosa in portal hypertension: The basis for increased susceptibility to injury, Dig Dis Sci 1989; 34:225-228.
4. Wenger J, Huffman RT, Landry MS: Persistent blood loss from the stomach of patients with cirrhosis and esophageal varices, South Med J 1970:63:560-566.
5. Babb RR, Mitchell RL: Persistent hemorrhagic gastritis in a patient with portal hypertension and esophagogastric varices: The role of portal decompressive surgery, Am J Gastroenterol 1988;83:777-779.
6. Hosking SW, Kennedy HJ, Seddon I, Triger DR: The role of propranolol in congestive gastropathy of portal hypertension, Hepatology 1987; 7:437-441.
7. Perez-Avuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, Rigau J, Quintero E, Valderrama R, Viver J, Esteban R, Rodrigo L, Bor-das JM, Rodes J: Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis, Lancet 1991;337: 431-434.
8. Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Elena M, Bosch J, Rodes J: Gastric mucosal vascular ectasias causing bleeding in cirrhosis: A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen 1, Gastroenterology 1987;93:1054-1061.
9. Triger DR, Hosking SW: The gastric mucosa in portal hypertension, J Hepatol 1989;85:267-272.
10. DeWeert TM, Gostout CJ, Wiesner RH: Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation, Am J Gastroenterol 1990:85:573-576.
11. Corbishley CM, Saverymuttu SH, Maxwell JD: Use of endoscopic biopsy for diagnosing congestive gastropathy, J Clin Pathol 1988:41: 1187-1190.
12. Panes J, Bordas JM, Pique JM, Bosch J, Garcia-Pagan JC, Feu F, Casadevall M, Teres J, Rodes J: Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy, Gastroenterology 1992;103:1875-1882.
13. Pancs J, Bordas JM, Pique JM, Garcia-Pagan JC, Feu F, Teres J, Bosch J, Rodes J: Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy, Hepatology 1993:17: 213-218.
14. McCormick PA, Sankey EA, Cardin F, Dhillon AP, McIntyre N, Burroughs AK: Congestive gastropathy and Helicobacter pylori: An endoscopic and morphometric study, Gut 1991;32:351-354.
15. Thiruvengadam R, Gostout CJ: Congestive gastroenteropathy - an extension of non-variceal upper gastrointestinal bleeding in portal hypertension, Gastrointest Endosc 1989;35:504-507.
16. Cales P Voigt JJ, Paven JL, Bloom E, Berg P, Vinel JP, Praderc B, Broussy P, Pascal JP: Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia: Lack of response to portosystemic shunt or gastrectomy, Gut 1993:34: 558-561.
17. Kozarek RA, Botoman VA, Brcd-fcldt JE, Roach JM, Patterson DJ, Ball TJ: Portal colopathy: Prospective study of colonoscopy in patients with portal hypertension, Gastroenterology 1991:101:1192-1197.
18. V iggiana TR, Gostout CJ: Portal hypertensive intestinal vasculopathy: A review of the clinical, endoscopic, and histopathologic features, Am J Gastroenterol 1992;87:944-954.
19. Sarfeh IJ, Tamawski A: Gastric mucosal vasculopathy in portal hypertension, Gastroenterology 1987:93:1129-1131.
20. Preble RB: Conclusions based on sixty cases of fatal gastrointestinal hemorrhage due to cirrhosis of the liver, Ant J Med Sci 1900:119:263.
21. Wangersteen OH: The ulcer problem, Can Med Assoc J 1945:53:309-331.
22. Palmer ED: Erosive gastritis in cirrhosis: Influence of portal hypertension on gastric mucosa, Am J Dig Dis 1957:2:31-36.
23. van Vlict ACM, ten Kate FJW, Dees J, van Blankenstein M: Abnormal blood vessels of the prepyloric antrum in cirrhosis of the liver as a cause of chronic gastrointestinal bleeding, Endoscopy 1978:10:89-94.
24. Sacchelti C, Capello M, Rebecchi P, Roncucci L, Zanghicri G, Tripodi A, De Leon MP: Frequency of upper gastrointestinal lesions in patients with liver cirrhosis, Dig Dis Sci 1988;33:1218-1222.
25. Teres J, Bordas JM, Bru C, Diaz F, Brugucra M, Rodes J: Upper gastrointestinal bleeding in cirrhosis: Clinical and endoscopic correlations, Gut 1976;17:37-40.
26. Bosch J, Masti R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodes J: Effect of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis, Hepatolo-gy 1984;4:1200-1205.
27. Waldram R, Davis M, Nunnerley H, Williams R: Emergency endoscopy after gastrointestinal hemorrhage in 50 patients with portal hypertension, Br Med J 1974;4:94-96.
28. KJiodadoost J, Glass GBJ: Erosive gastritis and acute gastroduodenal ulcerations as source of upper gastrointestinal bleeding in Iver cirrhosis, Digestion 1972;7:129-138.
29. Gostoul CJ, Viggiano TR, Balm RK: Acute gastrointestinal bleeding from portal hypertensive gastropa-thy: Prevalence and clinical features, Am J Gastroenterol 1993:88: 2030-2033.
30. D’amico G, Montalbano I, Traina M, Pisa R, Menozzi M, Spano C, Pagliaro L, and the Liver Group of V, Ccrvello Hospital: Natural history of congestive gastropathy in cirrhosis, Gastroenterology 1990:99: 1558-1564.
31. Smart HL, Triger DR: Clinical features, pathophysiology and relevance of portal hypertensive gastropathy, Endoscopy 1991:23:224-228.
32. Vigneri S, Termini R, Piraino A, Scialabba A, Pisciotta G, Fontana N: The stomach in liver cirrhosis, Endoscopic, morphological and clinical correlations, Gastroenterology 1991:101:472-478.
33. Hyams JS, Treem WR: Portal hypertensive gastropathy in children, J Pediatr Gastroenterol Nutr 1993; 17:13-18.
34. Lee FI, Costello F, Flanagan N, Vasudcv KS: Diffuse antral vascular ectasia, Gastrointcst Endosc 1984; 30:87-90.
35. Koivisto PVI: Gastric antral vascular ectasia and primary biliary cirrhosis, Endoscopy 1988:20:334.
36. Tsia HH, Smith J, Danesh BJ: Successful control of bleeding from gastric vascular ectasia (watermelon stomach) by laser photocoagulation, Gut 1991:32:93-94.
37. Calcs P, Payen JL, Berg P, Voigt JJ, Desmorat H, Vinci JP, Pascal JP: Antral vascular ectasia: New endoscopic and clinical spectrum, Gastroenterology 1991; 100:A38.
38. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA: Gastric antral vascular ectasia: The watermelon stomach, Gastroenterology 1984:87:1165-1170.
39. Tovey FI: Gastric antral vascular ectasia: The watermelon stomach, Gastroenterology 1985;88:1293.
40. Papazian A, Braillon A, Dupas JL, Sevenet F, Capron JP: Portal hypertensive gastric mucosa: An endoscopic study, Gut 1986:27:1199-1203.
41. Sarin SK, Misra SP, Singal A, Tho-rat V, Broor SL: Evaluation of the incidences and significance of the 'mosaic pattern' in patients with cirrhosis, non-cirrhotic portal fibrosis, and extrahepatic obstruction, Am J Gastroenterol 1988:83:1235-1239.
42. Spina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santam-brogio R, Rossi A: Gastric endoscopic features in portal hypertension: Final Report of a Consensus Conference, Milan, Italy, September 19, 1992, J Hepatol 1994:21:461-467.
43. Hashizume M, Tanaka K, Inokuchi K: Morphology of gastric microcirculation in cirrhosis, Hcpatology 1983:3:1008-1012.
44. Manabe T, Suzuki T, Honjo I: Changes of gastric blood flow in experimentally induced cirrhosis of the liver, Surg Gynecol Obstet 1978; 147:753-757.
45. Foster PN, Wyatt JI, Bullimorc DW, Losowsky MS: Gastric mucosa in patients with portal hypertension: Prevalence of capillary dilation and Campylobacter pylori, J Clin Pathol 1989:42:919-921.
46. Misra SP, Dwivedi M, Misra V, Agarwal SK, Gupta R, Gupta SC, Mital VP: Endoscopic and histologic appearance of the gastric mucosa in patients with portal hypertension, Gastrointcst Endosc 1990:36:575-579.
47. Perez-Ayuso RM, Pique JM, Saperas E, Bombi JA, Bordas JM, Elena M, Navarro S, Teres J: Gastric vascular ectasias in cirrhosis: Association wi.h hypoacidity not related to gastric atrophy, Scand J Gastroenterol 1989;24:1073-1078.
48. Lin W, Lee FY, Lin HC: Snake skin pattern gastropathy in cirrhotic patients, J Gastroenterol Hepatol 1991:6:145-149.
49. Thanouc K, Hashizume M, Wada H, Masayuki O, Kitano S, Sugima-chi K: Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: A prospective study, Gastrointcst Endose 1992:38: 582-585.
50. Sarin SK, Sreenivas DV, Lahoti D, Saraya A: Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension, Gastroenterology 1992; 102:994-999.
51. Jackson FC, Perrin EB, Felix WR, Smith AG: A clinical investigation of the portacaval shunt-V, survival analysis of the therapeutic operation, Ann Surg 1971; 174:672-701.
52. Resnick RH, lber FL, Ishihara AM, Chalmers TC, Zimmermann H: A controfcd study of the therapeutic portacaval shunt, Gastroenterology 1974;67:843-857.
53. Rueff B, Degos F, Degos JD, Maillard JN, Prandi D, Sicot J, Sicot C, Fauvert R: A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis, Lancet 1976;i:655-659.
54. Sarfeh IJ, Juler GL, Stemmer EA, Mason GR: Results of surgical management of hemorrhagic gastritis in patients with gastroesophageal varices, Surg Gynecol Obstet 1982:155: 167-170.
55. Pique JM, Leung FW, Kitahora T, Sarfeh IJ, Tamawski A, Gulh PH: Gastric mucosal blood flow and acid sccreticn in hypertensive rats, Gastroenterology 1988;95:727-733.
56. Gaur SK, Vij JC, Sarin SK, Anand BS: Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis, Digestion 1988:39:151-155.
57. Pique JM, Pizcueta P, Perez-Ayuso RM, Bosch J: Effects of propranolol on gastric microcirculation and acid sccreticn in portal hypertensive rats, Hepatology 1990;12:476-480.
58. Pienkowski P, Paven JL, Cales P, Monin JL, Pascal JP, Frexinos J: Functional assessment of gastric mucosal barrier in cirrhotic patients with portal hypertension by potential difference measurement, Gastroenterology 1989;96:A393.
59. Beck PL, McKnight GW, Kelly JK, Wallace JI., Lee SS: Hepatic and gastric cytoprotectivc effects of longterm prostaglandin El administration in cirrhotic rats, Gastroenterology'1993;105:1483-1489.
60. Nishizaki Y, Kaunitz JD, Oda M, Guth PH: Impairment of gastric mucosa defenses measured in vivo in cirrhotic rats, Hepatology 1994; 20:445-452.
61. Ichikawa Y, Tamawski A, Sarfch IJ, Ishikawa T, Shimada H: Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats, Gastroenterology 1994:106:702-708.
62. Beck PL, Lee SS, Wallace JL, McKnight GW: Cirrhotic rats have reduced levels of gastric prostaglandin E? and increased sensitivity to PGE induced gastric hyperemia, Gastroenterology 1991; 100:A32.
63. Vorobioi TJ, Bredfeldt JE, Grosz-man RJ: Hyperdynamic circulation in a portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension, Am J Physiol 1983;244:G52-G57.
64. Whittle BJR.: Nitric oxide in gastrointestinal physiology and pathology: in Johnson LR (ed): Physiology of the Gastrointestinal Tract, ed 3, New York, Raven Press, 1994, pp 267-294.
65. Holzcr P, Livingston EH, Guth PH: Neural, metabolic, physical and endothelial factors in the regulation of the gastric circulation; in Johnson LR (ed): Physiology of the Gastrointestinal Tract, ed 3, New York, Raven Press, 1994, pp 1211-1329.
66. Teppcrman BL, Jacobsen ED: Circulatory factors in gastric mucosal defense and repair, in Johnson LR (ed): Physiology of the Gastrointestinal Tract, ed 3, New York, Raven Press, 1994, pp 1331-1351.
67. Sicber C’C, Lopez-Talavcra JC, Groszman RJ: Role of nitric oxide in the in vivo splanchnic vascular hyporeactivity in ascitic cirrhotic rats, Gastroenterology 1993; 104: 1750-1754.
68. Fernandez M, Garcia-Pagan JC, Casadevall M, Bemadich C, Piera C, Whittier BJR., Pique JM, Bosch J, Rodes J: Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats, Gastroenterology 1995;108:1487-1495.
69. Panes J, Pique JM, Bosch J: Gastrointestinal mucosal hemodialysis in patients with portal hypertensive gastropathy, Gastroenterology 1993: 105:309-310.
70. Nishiwake H, Asai T, Sowa M, Umeyama K: Endoscopic measurement of gastric mucosal blood flow with special reference to the effects of sclerotherapy in patients with liver cirrhosis, Am J Gastroenterol 1990:85:34-37.
71. Koyanagi N, Inokuchi K, Matsuura K: Increased blood flow in the stomach of cirrhotic patients as assessed by radionuclide angiography, Eur Surg Res 1985:17:341-346.
72. Leung FW, Morishita M, Livingston EH, Reedy T, Guth PH: Reflectance spectrophotometry for the assessment of gastroduodenal mucosa! perfusion, Am J Physiol 1987:252: G797-G804.
73. Kiel JW, Riedel GL, DiRcsta GE, Shepherd AP: Gastric mucosal blood flow measured by Laser Doppler Velocimetrv, Am J Physiol 1985;249:G539-G545.
74. Iwao T, Tovonaga A, Ikegami M, Oho K, Sumino M, Harada H, Saka-ki M, Shigemori H, Aoki T, Tanika-wa K: Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy, Hcpatolo-gy 1993:18:36-40.
75. Kotzampassi K, Eleftheriadis E, Aletras H: Gastric mucosal blood flow in portal hypertension patients: A laser doppler flowmctry study, Hepato Gastroenterol 1992;39:39-42.
76. Benoit JN, Womack WA, Korthuis RJ, Wilborn WH, Granger DN: Chronic portal hypertension: Effects on gastrointestinal blood flow distribution, Am J Physiol 1986:250: G535-G539.
77. Sarfeh IJ, Tamawski A, Macda R, Raymont K, Mason GR, Ivey KJ: The gastric mucosa in portal hypertension: Effects of topical bile acid, Scand J Gastroenterol 1984:19 (suppl 92): 189-194.
78. Beck PL, Lee SS, McKnight GW, Wallace JL: Characterization of spontaneous and ethanol induced gastric damage in cirrhotic rats, Gastroenterology 1992;103:1048-1055.
79. Albillos A, Colombato LA, Enriquez R, Ng OC, Sikuler E, Groszman RJ: Sequence of morphological and hemodynamic changes of gastric mi-crovcssels in portal hypertension, Gastroenterology 1992; 102:2066-2070.
80. Chojkier M, Groszman RJ: Measurement of portal-systemic shunting in the rat by using y-labeled microspheres, Am J Physiol 1981;240: G371-G375.
81. Bosch J, Enriquez R, Groszman RJ, Storcr EH: Chronic bile duct ligation in the dog: Hemodynamic characterization of a portal hypertensive model, Hepatology 1983:3:1002-1007.
82. Saperas E, Perez-Ayuso RM, Poca E, Bordas JM, Gaya J, Pique JM: Increased gastric PGE; biosynthesis in cirrhotic patients with gastric vascular ectasia, Am J Gastroenterol 1990:85:138-144.
83. Arakawa T, Satoh H, Fukuda T, Nakamura H, Kobayashi K: Endogenous prostaglandin E; in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension, Gastroenterology 1987;93:135-140.
84. Wcilcr H, Weiler CH, Gerok W: Decreased prostaglandin E; imntu-noactivity of gastric mucosa in portal hypertension, Neth J Med 1991; 38:4-12.
85. Solis-Herruzo JA, Pardo-Rueda J: Functional study of the gastric mucosal barrier in hepatic cirrhosis, Acta Hepato-Gastroentcrol 1976; 23:351-359.
86. Guslandi M, Foppa L, Sorghi M, Pellegrini A, Fanti L, Tittobello A: Breakdown of mucosal defense in congestive gastropathy in cirrhotics, Liver 1992:12:303-305.
87. Sarfch IJ, Tamawski A, Malki A, Mason GR, Mach T, Ivey KJ: Portal hypertension and gastric mucosa injury in rats, Effects of alcohol, Gastroenterology 1983:84:987-993.
88. Rokkas T, Purscv C, Uzoechina E, Dorrington L, Simmons NA, Filipe ML, Sladen GE, Campylobacter pylori and non-ulcer dyspepsia, Am J Gastroenterol 1987;82:1149-1152.
89. Pettross CW, Appleman MD, Cohen H, Valenzuela JH, Chandraso-raa P, Laine LA: Prevalence of Campylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms, Dig Dis Sci 1988:33:649-653.
90. Bosch J, Garcia-Pagan G, Feu F, Luca A, Fernandez M, Pizuceta P, Rodes J: New approaches in the pharmacologic treatment of portal hypertension, J Flepatol 1993; 17(suppl 2): S41-S45.
91. Lebrec D: Current status and future goals of the pharmacologic reduction of portal hypertension, Am J Surg 1990;160:19-25.
92. Lebrec D, Hillon P, Munoz C, Gold-farb G, Nouel O, Benhamou JP: The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study, I lepatology 1982:2:523-527.
93. Feu F, Bordas JM, Luca A, Garcia-Pagan JC, Escorscll A, Bosch J, Rodes J: Reduction of variceal pressure by propranolol: Comparison of the effects on portal pressure and azygos blood How in patients with cirrhosis, Hepatology 1993:18: 1082-1089.
94. Vorobioff J, Picabca E, Villavicen-cio R, Puccini V, Rossi O, Bordato J, Audano M: Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients, Hepatology 1987;7:648-653.
95. Lebrec D, Povnard T, Bernuau J, Bercoff E, Nouel O, Capron JP, Poupon R, Bouvry M, Rueff B, Benhamou JP: A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report, Hepatology 1984:4:355-358.
96. Quintero E, Pique JM, Bombi JA: Antral mucosal hyperemia: Characterization of a portal hypertension related syndrome causing gastric bleeding in patients with cirrhosis, J Hepatol 1985:1 (suppl 2): S315.
97. Bosch J, Bruix J, Mas A, Navasa M, Rodes J: Rolling review: The treatment of major complications of cirrhosis, Aliment Pharmacol Ther 1994;8:639-657.
98. Tarver D, Walt RP, Dunk AA, Jenkins WJ, Sherlock S: Precipitation of hepatic encephalopathy by propranolol in cirrhosis, Br Med J 1983:287:585.
99. Rector WG, Reynolds TB: Propranolol in the treatment of cirrhotic patients, Arch Intern Med 1984;144:1761-1763.
100. Henriksen JH, Ring-Larsen H: Renal effects of drugs used in the treatment of portal hypertension, Hepatology 1993:18:688-695.
101. Panes J, Pique JM, Bordas JM, Llach J, Bosch J, Teres J, Rodes J: Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy, Hepatology 1994;19:55-60.
102. Orloff MJ, Orloflf MS, Orlof TSL, Haynes KS: Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt, Hepatology 1995:21:1011-1017.
103. Peine CJ, Freeman ML, Miller RP, Stanchfield WR, Castaneda WR: Resolution of congestive gastropathy using transjugular intrahepatic portosystemic stents, Hepatology 1992:16:245A.
104. Wu Y, Burns C, Sitzmann JV: Effects of nitric oxide and cyclooxy-genase inhibition on splanchic hemodynamics in portal hypertension, Hepatology 1993:18:1416-1421.
105. Panes J, Casadevall M, Fernandez M, Pique JM, Bosch J, Casamitja-na R, Cirera I, Bombi JA, Teres J, Rodes J: Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogcn-progeslogen treatment, Hepatology 1994:20:1261-1270.
106. Lee SS, Sharkey KA: Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats, Am J Physiol 1993;264:G868-G873.